SCHEMBL5311119

SCHEMBL5311119

CCn1ccc2cc(NN)ccc2c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 5/20 0.45
▸ CHEK1 O14757 3/20 0.45
▸ GRM2 Q14416 1/20 0.40
▸ GRM4 Q14833 2/20 0.39
▸ MAPT P10636 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ LMNA P02545 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ KIT P10721 2/20 0.36
▸ HDAC3 O15379 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ POLB P06746 2/20 0.35
▸ TNF P01375 2/20 0.34
▸ NLRP3 Q96P20 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5313087 0.88 GRM2 (0.52) FLT3CHEK1GRM2GRM4HDAC3
SCHEMBL5308632 0.84 HDAC3 (0.48) FLT3CHEK1GRM2GRM4KDM4E
SCHEMBL5310274 0.82 HTR6 (0.43) GRM2GRM4TDP1HDAC3HDAC1
SCHEMBL5314964 0.82 RXFP1 (0.41) GRM2GRM4MAPTKDM4ERXFP1
SCHEMBL5311595 0.80 ACHE (0.44) MAPTLMNARXFP1POLB
SCHEMBL5311724 0.80 FLT3 (0.50) FLT3CHEK1GRM2GRM4LMNA
SCHEMBL5308849 0.80 CHEK1 (0.42) FLT3CHEK1GRM4MAPTMEN1
SCHEMBL5309410 0.78 ALDH1A1 (0.43) GRM2GRM4KDM4ELMNAHDAC3
SCHEMBL5312433 0.78 HSP90AB1 (0.58) GRM2KDM4EHDAC1HDAC6L3MBTL1
SCHEMBL5310870 0.78 MAPT (0.47) MAPTMEN1KMT2AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007053352-A2 PYRROLOQUINOLINONE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2007-05-10 — — WO disclosed
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2007-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands HTR6, HTR5A, HTR2C FLT3 2397/4885CHEK1 4649/4885GRM2 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback